You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (36) |
Back to Search
The role of pharmacokinetics in bioequivalence of studies of inhalation drugs
- In: MINI-SYMPOSIUM: CHALLENGES IN BIOEQUIVALENCE FOR INHALED PRODUCTS on Monday, 14 April 2014, 09:00-10:00
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: HOCHHAUS, Guenther (University of Florida, Pharmaceutics, Gainesville, United States of America)
- Abstract:
I. Background: Demonstrating the bioequivalence of inhaltion drugs is a challenge. Currently in vitro, pharmacokinetic and pharmacodynamic clinical studies are employed with european (EMA) and north-american (FDA) differing significantly 2. Aims: Aim of this presentation is it to discuss advantages and disadvantages of above methods. 3. Methods:..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026